Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
Titel:
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
Auteur:
Egberts, F. Gutzmer, R. Ugurel, S. Becker, J.C. Trefzer, U. Degen, A. Schenck, F. Frey, L. Wilhelm, T. Hassel, J.C. Schadendorf, D. Livingstone, E. Mauch, C. Garbe, C. Berking, C. Rass, K. Mohr, P. Kaehler, K.C. Weichenthal, M. Hauschild, A.